Sabon maye gurbi na 'arcturus' na COVID yana haifar da alamu daban-daban a cikin yara

TAMPA.Masu bincike a halin yanzu suna sa ido kan wani nau'in ƙwayar cuta ta micromicron COVID-19 XBB.1.16, wanda kuma aka sani da arcturus.

"Abubuwa suna da alama suna haɓaka kaɗan," in ji Dokta Michael Teng, masanin ilimin ƙwayoyin cuta kuma masanin farfesa a lafiyar jama'a a USF.
Dokta Thomas Unnash, wani mai bincike kuma kwararre a fannin kiwon lafiyar jama'a ya ce "Hakika ya buge ni saboda wannan kwayar cutar ta riga ta zama kwayar cutar da mutum ya sani. Don haka a gaskiya ban san lokacin da wannan zai daina ba."
Arcturus ne ke da alhakin hauhawar halin yanzu a lokuta a Indiya, wanda ke ba da rahoton sabbin maganganu 11,000 kowace rana.
Hukumar lafiya ta duniya ta sanar da cewa tana bin diddigin kwayar cutar saboda a halin yanzu ana samunta a kasashe da dama.An sami wasu lokuta a Amurka.Dangane da sabbin bayanai daga CDC, yana lissafin kusan kashi 7.2% na sabbin lokuta.

"Ina tsammanin za mu ga girma kuma ina tsammanin za mu ga wani abu makamancin abin da suke gani a Indiya," in ji Unnash.Duk da haka, sun gano cewa ya shafi yara da yawa, yana haifar da alamun da suka bambanta da sauran maye gurbi, ciki har da ciwon ido da zazzabi mai zafi.

“Ba wai a da ba mu gan shi ba.Yana faruwa sau da yawa, ”in ji Ten.
Jami'an kiwon lafiya sun ce yayin da bera mai kahon ke ci gaba da yaduwa, muna sa ran karin yara za su kamu da cutar.
"Ina tsammanin wani abu da watakila muke gani a Indiya shine shaida ta farko da ke nuna cewa wannan na iya zama cutar yara.Wannan shine inda yawancin ƙwayoyin cuta ke ƙarewa, ”in ji Unnash.
Zabin zaɓin ya zo ne lokacin da FDA kawai ta sake duba jagorarta don allurar rigakafi, ta ba su damar duk allurai da aka ba wa mutane watanni shida da haihuwa, gami da ƙarin allurai don wasu al'ummomi.
Sabbin jagororin sun haɗa da shawarwarin cewa mutane masu shekaru 65 zuwa sama su sami kashi na biyu na rigakafin bivalent watanni huɗu bayan kashi na farko.
Har ila yau, FDA ta ba da shawarar cewa yawancin mutanen da ke fama da rigakafi su sami ƙarin allurai aƙalla watanni biyu bayan kashi na farko na rigakafin bivalent.
"Kamar yadda muke damuwa game da karuwar kamuwa da cututtuka tare da bambance-bambancen da ke yaduwa, yanzu ne lokacin da za ku fara inganta rigakafi ta yadda idan muka ga ƙarin lokuta na wannan sabon bambance-bambancen, ku san tsarin garkuwar jikin ku zai kasance a shirye don yaƙar shi. " in ji Tan.